This new 269-page report from Venture Planning Group provides a comprehensive analysis in the French endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.
During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
Strategies for the French Endocrine Function Testing Market? is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.
Contains 269 pages and 16 tables
SIMILAR MARKET STUDIES
2017 Europe Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies-France, Germany, Italy, Spain, UK
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European blood banking market during the next five years, and assist industry executives in developing effective business, new product ...
March 2017 | $0 | View Details >>
Complete report $6,800. DataPack (test volumes, sales forecasts, supplier shares) $3,950.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes potential ...
June 2016 | $0 | View Details >>
This new report from VPGMarketResearch.com provides analysis of Vancomycin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment
October 2014 | $0 | View Details >>
TechNavio's analysts forecast the Global HPV Testing market to grow at a CAGR of 19.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in risk of the number of people prone to HPV. The Global HPV Testing market has also ...
January 2014 | $2500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research